These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 10955925
1. Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome. Kemper MJ, Altrogge H, Ludwig K, Timmermann K, Müller-Wiefel DE. Pediatr Nephrol; 2000 Aug; 14(8-9):772-5. PubMed ID: 10955925 [Abstract] [Full Text] [Related]
3. HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome. Konrad M, Mytilineos J, Ruder H, Opelz G, Schärer K. Pediatr Nephrol; 1997 Feb; 11(1):16-9. PubMed ID: 9035165 [Abstract] [Full Text] [Related]
4. Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Zagury A, de Oliveira AL, de Moraes CA, de Araujo Montalvão JA, Novaes RH, de Sá VM, Monteiro de Carvalho Dde B, Matuck T. Pediatr Nephrol; 2011 Jun; 26(6):915-20. PubMed ID: 21399901 [Abstract] [Full Text] [Related]
6. Management Of Childhood Steroid Dependent Nephrotic Syndrome With Cyclophosphamide - An Experience At Ayub Teaching Hospital, Abbottabad. Hussain Shah SS, Aalia B, Raza A, Najeeb S, Rehman AU. J Ayub Med Coll Abbottabad; 2021 Jun; 33(2):213-216. PubMed ID: 34137531 [Abstract] [Full Text] [Related]
7. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome]. Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases. Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389 [Abstract] [Full Text] [Related]
8. Histopathological Spectrum and Short-Term Outcome of Treatment with Cyclophosphamide in Relapsing Steroid-Sensitive Nephrotic Syndrome. Bajeer IA, Khatri S, Tresa V, Hashmi S, Mubarak M, Lanewala AA. J Coll Physicians Surg Pak; 2018 Jun; 28(6):436-439. PubMed ID: 29848418 [Abstract] [Full Text] [Related]
9. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Kyrieleis HA, Levtchenko EN, Wetzels JF. Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840 [Abstract] [Full Text] [Related]
10. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome. Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ. Nephrol Dial Transplant; 2004 May; 19(5):1136-41. PubMed ID: 14993510 [Abstract] [Full Text] [Related]
11. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus. Sinha MD, MacLeod R, Rigby E, Clark AG. Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257 [Abstract] [Full Text] [Related]
12. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie. Arch Dis Child; 1987 Nov; 62(11):1102-6. PubMed ID: 3688915 [Abstract] [Full Text] [Related]
13. Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome. Mizutani A, Fujinaga S, Sakuraya K, Hirano D, Shimizu T. Clin Exp Nephrol; 2019 Feb; 23(2):244-250. PubMed ID: 30121800 [Abstract] [Full Text] [Related]
14. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence. Srivastava RN, Agarwal RK, Choudhry VP, Moudgil A, Bhuyan UN, Sunderam KR. Int J Pediatr Nephrol; 1985 Feb; 6(4):245-50. PubMed ID: 4093243 [Abstract] [Full Text] [Related]
15. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J. Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923 [Abstract] [Full Text] [Related]
16. Steroid-responsive relapsing nephrotic syndrome associated with early diabetic glomerulopathy in a child. Peces R, Riera JR, López Larrea C, Alvarez J. Nephron; 1987 Jul; 46(1):78-82. PubMed ID: 3600916 [Abstract] [Full Text] [Related]
17. Therapeutic effect of chai-ling-tang (sairei-to) on the steroid-dependent nephrotic syndrome in children. Liu XY. Am J Chin Med; 1995 Jul; 23(3-4):255-60. PubMed ID: 8571921 [Abstract] [Full Text] [Related]
18. Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth. Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, McDonald BM, Siegel NJ. Am J Kidney Dis; 1987 Feb; 9(2):108-14. PubMed ID: 3826059 [Abstract] [Full Text] [Related]
19. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Bagga A, Hari P, Moudgil A, Jordan SC. Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181 [Abstract] [Full Text] [Related]
20. The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases-M1 and -P1. Vester U, Kranz B, Zimmermann S, Büscher R, Hoyer PF. Pediatr Nephrol; 2005 Apr; 20(4):478-81. PubMed ID: 15717164 [Abstract] [Full Text] [Related] Page: [Next] [New Search]